Danish share prices closed higher on Thursday, with sector strength in Consumer Goods, Personal & Household Goods and Chemicals supporting overall gains. At the close in Copenhagen the OMX Copenhagen 20 index added 0.40%.
Among the index constituents, Zealand Pharma A/S (CSE:ZELA) led the winners, finishing the session up 3.85% - a rise of 10.90 points - to close at 294.30. Pandora A/S (CSE:PNDORA) also recorded a solid advance, climbing 2.95% or 18.20 points to end the day at 635.80. DSV Panalpina A/S (CSE:DSV) was higher as well, gaining 2.18% or 33.50 points to finish at 1,573.00 in late trade.
On the losing side, FLSmidth & Co. (CSE:FLS) fell 2.10%, a decline of 10.20 points, to close at 474.40. Coloplast A/S (CSE:COLOb) declined 1.77% or 6.80 points to finish at 376.30, a move that took the stock to a five-year low. Novozymes AS (CSE:NSISb) slipped 1.50%, losing 5.90 points to end the session at 386.40.
Market breadth was positive, with 64 stocks higher versus 49 declining on the Copenhagen exchange, while 19 issues finished unchanged.
Commodities showed mixed performance during the session. Crude oil for July delivery rose 0.49% or 0.44 to trade at $90.47 a barrel. Brent oil for August delivery dipped 0.17% or 0.16 to $92.94 a barrel. Gold futures for August moved lower by 0.72% or 29.75, trading at 4,103.55 a troy ounce.
Currency measures tied to the Danish krone were also active. The USD/DKK rate increased 0.12% to 6.49, while EUR/DKK was essentially unchanged, moving 0.02% to 7.47. The US Dollar Index Futures was higher as well, up 0.24% at 100.18.
Market participants will note the specific moves among index members: notable gains in select consumer and logistics-related names contrasted with weakness among industrials and life sciences names during the session. The net effect was a modestly higher index at the close.